Cargando…

United Kingdom health research analyses and the benefits of shared data

BACKGROUND: To allow research organisations to co-ordinate activity to the benefit of national and international funding strategies requires assessment of the funding landscape; this, in turn, relies on a consistent approach for comparing expenditure on research. Here, we discuss the impact and bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, James G., Sherbon, Beverley J., Viney, Ian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919875/
https://www.ncbi.nlm.nih.gov/pubmed/27342284
http://dx.doi.org/10.1186/s12961-016-0116-1
_version_ 1782439314601279488
author Carter, James G.
Sherbon, Beverley J.
Viney, Ian S.
author_facet Carter, James G.
Sherbon, Beverley J.
Viney, Ian S.
author_sort Carter, James G.
collection PubMed
description BACKGROUND: To allow research organisations to co-ordinate activity to the benefit of national and international funding strategies requires assessment of the funding landscape; this, in turn, relies on a consistent approach for comparing expenditure on research. Here, we discuss the impact and benefits of the United Kingdom’s Health Research Classification System (HRCS) in national landscaping analysis of health research and the pros and cons of performing large-scale funding analyses. METHODS: The first United Kingdom health research analysis (2004/2005) brought together the 11 largest public and charity funders of health research to develop the HRCS and use this categorisation to examine United Kingdom health research. The analysis was revisited in 2009/2010 and again in 2014. The most recent quinquennial analysis in 2014 compiled data from 64 United Kingdom research organisations, accounting for 91% of all public/charitable health research funding in the United Kingdom. The three analyses summarise the United Kingdom’s health research expenditure in 2004/2005, 2009/2010 and 2014, and can be used to identify changes in research activity and disease focus over this 10 year period. RESULTS: The 2004/2005 analysis provided a baseline for future reporting and evidence for a United Kingdom Government review that recommended the co-ordination of United Kingdom health research should be strengthened to accelerate the translation of basic research into clinical and economic benefits. Through the second and third analyses, we observed strategic prioritisation of certain health research activities and disease areas, with a strong trend toward increased funding for more translational research, and increases in specific areas such as research on prevention. CONCLUSIONS: The use of HRCS in the United Kingdom to analyse the research landscape has provided benefit both to individual participatory funders and in coordinating initiatives at a national level. A modest amount of data for each project is sufficient for a nationwide assessment of health research funding, but achieving coverage of the United Kingdom portfolio relies on sourcing these details from a large number of individual funding agencies. The effort needed to compile this data could be minimised if funders routinely shared or published this information in a standard and accessible way. The United Kingdom approach to landscaping analyses could be readily adapted to suit other groups or nations, and global availability of research funding data would support better national and international coordination of health research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12961-016-0116-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4919875
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49198752016-06-25 United Kingdom health research analyses and the benefits of shared data Carter, James G. Sherbon, Beverley J. Viney, Ian S. Health Res Policy Syst Commentary BACKGROUND: To allow research organisations to co-ordinate activity to the benefit of national and international funding strategies requires assessment of the funding landscape; this, in turn, relies on a consistent approach for comparing expenditure on research. Here, we discuss the impact and benefits of the United Kingdom’s Health Research Classification System (HRCS) in national landscaping analysis of health research and the pros and cons of performing large-scale funding analyses. METHODS: The first United Kingdom health research analysis (2004/2005) brought together the 11 largest public and charity funders of health research to develop the HRCS and use this categorisation to examine United Kingdom health research. The analysis was revisited in 2009/2010 and again in 2014. The most recent quinquennial analysis in 2014 compiled data from 64 United Kingdom research organisations, accounting for 91% of all public/charitable health research funding in the United Kingdom. The three analyses summarise the United Kingdom’s health research expenditure in 2004/2005, 2009/2010 and 2014, and can be used to identify changes in research activity and disease focus over this 10 year period. RESULTS: The 2004/2005 analysis provided a baseline for future reporting and evidence for a United Kingdom Government review that recommended the co-ordination of United Kingdom health research should be strengthened to accelerate the translation of basic research into clinical and economic benefits. Through the second and third analyses, we observed strategic prioritisation of certain health research activities and disease areas, with a strong trend toward increased funding for more translational research, and increases in specific areas such as research on prevention. CONCLUSIONS: The use of HRCS in the United Kingdom to analyse the research landscape has provided benefit both to individual participatory funders and in coordinating initiatives at a national level. A modest amount of data for each project is sufficient for a nationwide assessment of health research funding, but achieving coverage of the United Kingdom portfolio relies on sourcing these details from a large number of individual funding agencies. The effort needed to compile this data could be minimised if funders routinely shared or published this information in a standard and accessible way. The United Kingdom approach to landscaping analyses could be readily adapted to suit other groups or nations, and global availability of research funding data would support better national and international coordination of health research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12961-016-0116-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-24 /pmc/articles/PMC4919875/ /pubmed/27342284 http://dx.doi.org/10.1186/s12961-016-0116-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Carter, James G.
Sherbon, Beverley J.
Viney, Ian S.
United Kingdom health research analyses and the benefits of shared data
title United Kingdom health research analyses and the benefits of shared data
title_full United Kingdom health research analyses and the benefits of shared data
title_fullStr United Kingdom health research analyses and the benefits of shared data
title_full_unstemmed United Kingdom health research analyses and the benefits of shared data
title_short United Kingdom health research analyses and the benefits of shared data
title_sort united kingdom health research analyses and the benefits of shared data
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919875/
https://www.ncbi.nlm.nih.gov/pubmed/27342284
http://dx.doi.org/10.1186/s12961-016-0116-1
work_keys_str_mv AT carterjamesg unitedkingdomhealthresearchanalysesandthebenefitsofshareddata
AT sherbonbeverleyj unitedkingdomhealthresearchanalysesandthebenefitsofshareddata
AT vineyians unitedkingdomhealthresearchanalysesandthebenefitsofshareddata